ZA981391B - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
ZA981391B
ZA981391B ZA981391A ZA981391A ZA981391B ZA 981391 B ZA981391 B ZA 981391B ZA 981391 A ZA981391 A ZA 981391A ZA 981391 A ZA981391 A ZA 981391A ZA 981391 B ZA981391 B ZA 981391B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
ZA981391A
Inventor
Masayuki Yamanaka
Satoshi Ueda
Rinta Ibuki
Fumio Shimojo
Toshihiko Toyoda
Norio Ohnishi
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of ZA981391B publication Critical patent/ZA981391B/en

Links

ZA981391A 1997-02-20 1998-02-19 Pharmaceutical composition ZA981391B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3617297 1997-02-20

Publications (1)

Publication Number Publication Date
ZA981391B true ZA981391B (en) 1998-08-24

Family

ID=12462338

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA981391A ZA981391B (en) 1997-02-20 1998-02-19 Pharmaceutical composition

Country Status (1)

Country Link
ZA (1) ZA981391B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2798467C1 (en) * 2023-03-28 2023-06-23 Федеральное государственное автономное образовательное учреждение высшего образования "Пермский государственный национальный исследовательский университет" 2a-alkoxycarbonyl-5-phenyl-1h-spiro[cyclopropa[2,3]pyrrolo[1,2-a]quinoxaline-3,3'-indoline]-1,2,2',4(2ah,5h)-tetraons

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2798467C1 (en) * 2023-03-28 2023-06-23 Федеральное государственное автономное образовательное учреждение высшего образования "Пермский государственный национальный исследовательский университет" 2a-alkoxycarbonyl-5-phenyl-1h-spiro[cyclopropa[2,3]pyrrolo[1,2-a]quinoxaline-3,3'-indoline]-1,2,2',4(2ah,5h)-tetraons

Similar Documents

Publication Publication Date Title
GB9706089D0 (en) Pharmaceutical composition
GB9727053D0 (en) Pharmaceutical compositions
CY2569B1 (en) Pharmaceutical compositions
EP0978288A4 (en) Medicinal composition
GB9818591D0 (en) Pharmaceutical composition
IL133928A0 (en) Pharmaceutical composition containing peptichemio
GB9717444D0 (en) Pharmaceutical composition
HUP0002455A3 (en) Gastric-retained pharmaceutical composition
GB9717428D0 (en) Pharmaceutical composition
GB9723985D0 (en) Pharmaceutical compositions
HUP0004669A3 (en) Pharmaceutical compositions
IL122920A (en) Castrointestinal drug composition
EP1124557A4 (en) Pharmaceutical composition
HU9700632D0 (en) Pharmaceutical compositions
GB9623962D0 (en) Pharmaceutical composition
GB9717770D0 (en) Pharmaceutical composition
GB2321190B (en) Pharmaceutical composition
GB9921495D0 (en) Pharmaceutical compositions
GB9726781D0 (en) Pharmaceutical composition
GB9712097D0 (en) Pharmaceutical composition
GB9717575D0 (en) Pharmaceutical composition
GB9710632D0 (en) Pharmaceutical composition
GB9702517D0 (en) Pharmaceutical composition
GB9710525D0 (en) Pharmaceutical composition
HU9701598D0 (en) Pharmaceutical composition